Medipower -M Cash Flow Conversion Efficiency
Medipower -M cash flow conversion efficiency. Based on the latest financial reports, Medipower -M (MDPR) has a cash flow conversion efficiency ratio of 0.025x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA5.21 Million ≈ $13.96K USD) by net assets (ILA205.71 Million ≈ $551.51K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medipower -M (2012–2025)
Cash flow conversion efficiency of Medipower -M from 2012 to 2025. This chart illustrates how Medipower -M's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medipower -M stock price for real-time trading data and today's change.
Medipower -M Cash Flow Conversion Ratio Explained
Medipower -M cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medipower -M Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medipower -M ranked by their cash flow conversion efficiency. Also see market value of Medipower -M for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sinkang Industries Co Ltd
TW:2032
|
-0.040x |
|
Super Dragon Technology Co Ltd
TW:9955
|
0.036x |
|
Wspierania Przedsiebiorczosci
WAR:PTW
|
0.003x |
|
ad pepper media International N.V
XETRA:APM
|
0.095x |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
-0.479x |
|
Wentel Engineering Holdings Berhad
KLSE:0298
|
0.039x |
|
EN Shoham Business Ltd
TA:SHOM
|
-0.068x |
|
Haemato AG
HM:HAEK
|
N/A |
Annual Cash Flow Conversion Efficiency for Medipower -M (2012–2025)
The table below shows the annual cash flow conversion efficiency of Medipower -M from 2012 to 2025. Review Medipower -M free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA167.55 Million ≈ $449.19K |
ILA17.80 Million ≈ $47.72K |
0.106x | +1.53% |
| 2024-12-31 | ILA151.53 Million ≈ $406.26K |
ILA15.86 Million ≈ $42.51K |
0.105x | +23.26% |
| 2023-12-31 | ILA141.36 Million ≈ $378.98K |
ILA12.00 Million ≈ $32.17K |
0.085x | -13.19% |
| 2022-12-31 | ILA132.20 Million ≈ $354.43K |
ILA12.93 Million ≈ $34.66K |
0.098x | +14.46% |
| 2021-12-31 | ILA111.22 Million ≈ $298.18K |
ILA9.50 Million ≈ $25.47K |
0.085x | -18.18% |
| 2020-12-31 | ILA80.93 Million ≈ $216.96K |
ILA8.45 Million ≈ $22.65K |
0.104x | +14.85% |
| 2019-12-31 | ILA78.17 Million ≈ $209.58K |
ILA7.11 Million ≈ $19.05K |
0.091x | +26.40% |
| 2018-12-31 | ILA75.40 Million ≈ $202.14K |
ILA5.42 Million ≈ $14.54K |
0.072x | +28.41% |
| 2017-12-31 | ILA74.57 Million ≈ $199.93K |
ILA4.18 Million ≈ $11.20K |
0.056x | -19.30% |
| 2016-12-31 | ILA52.26 Million ≈ $140.10K |
ILA3.63 Million ≈ $9.72K |
0.069x | +295.73% |
| 2015-12-31 | ILA34.84 Million ≈ $93.40K |
ILA611.00K ≈ $1.64K |
0.018x | -52.60% |
| 2014-12-31 | ILA36.97 Million ≈ $99.12K |
ILA1.37 Million ≈ $3.67K |
0.037x | +17.41% |
| 2013-12-31 | ILA37.92 Million ≈ $101.65K |
ILA1.20 Million ≈ $3.20K |
0.032x | +301.78% |
| 2012-12-31 | ILA125.74 Million ≈ $337.09K |
ILA-1.96 Million ≈ $-5.27K |
-0.016x | -- |
About Medipower -M
Medipower (Overseas) Public Co. Limited, together with its subsidiaries, operates as a commercial real estate company in the United States, Canada, and Bulgaria. It engages in the acquisition, rental, redevelopment, operation, and management of commercial income-generating real estate, primarily retail properties. The company was incorporated in 2001 and is based in Nicosia, Cyprus.